Related Targets |
Mechanism GR agonists [+6] |
Active Org. |
Originator Org. |
Inactive Indication |
Drug Highest PhaseApproved |
First Approval Ctry. / Loc. US |
First Approval Date18 Sep 2017 |
Mechanism M1 receptor antagonists [+5] |
Active Org. |
Originator Org. |
Active Indication |
Inactive Indication- |
Drug Highest PhaseApproved |
First Approval Ctry. / Loc. US |
First Approval Date18 Dec 2013 |
Mechanism GR agonists [+6] |
Active Org. |
Originator Org. |
Active Indication |
Inactive Indication- |
Drug Highest PhaseApproved |
First Approval Ctry. / Loc. CN |
First Approval Date01 Jan 1981 |
Start Date29 Feb 2024 |
Sponsor / Collaborator |
Start Date20 Jan 2024 |
Sponsor / Collaborator |
Start Date06 Jun 2023 |
Sponsor / Collaborator |